Showing 9,101 - 9,120 results of 18,496 for search 'significantly ((((((greater decrease) OR (largest decrease))) OR (mean decrease))) OR (a decrease))', query time: 0.67s Refine Results
  1. 9101

    Video 3_Takotsubo syndrome following mitral transcatheter edge-to-edge repair: a case report and literature review.mp4 by Si Pang (5959094)

    Published 2025
    “…Despite the procedural success, multi-lead T-wave inversions and a 43% decrease in ejection fraction accompanied by new apical hypokinesis were noted postoperatively. …”
  2. 9102

    <b>Feature-based molecular networking of two Arenga species extracts, appraisal of their anti-inflammatory, analgesic and antidiarrheal activity</b>: Raw data (LC-MS/MS) by Wafaa A. Ahmed (21667440)

    Published 2025
    “…Also, it decreased the gastrointestinal motility in charcoal meal protocol and a showed an inhibitory effect on gastrointestinal motility with all investigated doses. …”
  3. 9103

    Supplemental Figures by Danielle A. Jeffrey (21187329)

    Published 2025
    “…FXR1 has seven isoforms, including isoforms mostly expressed in skeletal and cardiac tissue, and play a significant role in heart development and function. …”
  4. 9104

    Effects of Semaglutide and Dapagliflozin on Neuronal Integrity, Apoptosis, and LRP1 Expression in the Hippocampal CA1 Region of T2DM Mice. by Yan Zhu (112437)

    Published 2025
    “…(D) Quantitative analysis of LRP1 expression shows significantly decreased levels in the T2DM group compared to control (***<i>p</i> < 0.001), while both semaglutide and da<i>p</i>agliflozin treatment significantly restored LRP1 expression compared to the T2DM group (***<i>p</i> < 0.001). …”
  5. 9105
  6. 9106

    Table 1_The real-world safety of Nivolumab: a pharmacovigilance analysis based on the FDA adverse event reporting system.docx by Yutong Wu (3130584)

    Published 2025
    “…</p>Methods<p>We compiled a real-world safety dataset of nivolumab from the FDA Adverse Event Reporting System (FAERS) database, encompassing reports from Q4–2014 through Q2 2024. …”
  7. 9107

    Data Sheet 1_Cytosolic phospholipase A2 links tau pathology to insulin signaling impairment in Alzheimer’s disease.pdf by Faruk Hossen (20275670)

    Published 2025
    “…Specifically, we found significant decreases in insulin receptor-α (IR-α) and insulin receptor-β (IR-β) expression, along with increased levels of phospho-insulin receptor substrate 1 at Ser307 [p-IRS-1 (Ser307)] and decreased levels of p-IRS-1 (Tyr895), compared to wild-type (WT) mice. …”
  8. 9108

    S3 File - by Zi-Yun Yi (19859589)

    Published 2024
    “…In contrast, MII oocytes in the TSD group showed a decrease in the mtDNA copy number and a lower Δψm compared with the controls. …”
  9. 9109

    S2 File - by Zi-Yun Yi (19859589)

    Published 2024
    “…In contrast, MII oocytes in the TSD group showed a decrease in the mtDNA copy number and a lower Δψm compared with the controls. …”
  10. 9110

    Image_2_A sexually dimorphic signature of activity-dependent BDNF signaling on the intrinsic excitability of pyramidal neurons in the prefrontal cortex.TIF by Kaijie Ma (6065156)

    Published 2024
    “…A common single nucleotide polymorphism (SNP) in the pro-domain of the human BDNF gene that leads to a methionine (Met) substitution for valine (Val) at codon 66 (Val66Met) significantly decreases activity-dependent BDNF release without affecting basal BDNF secretion. …”
  11. 9111

    Image_1_A sexually dimorphic signature of activity-dependent BDNF signaling on the intrinsic excitability of pyramidal neurons in the prefrontal cortex.TIF by Kaijie Ma (6065156)

    Published 2024
    “…A common single nucleotide polymorphism (SNP) in the pro-domain of the human BDNF gene that leads to a methionine (Met) substitution for valine (Val) at codon 66 (Val66Met) significantly decreases activity-dependent BDNF release without affecting basal BDNF secretion. …”
  12. 9112

    Table 1_Factors affecting health-seeking behavior in sports climbers in Metro Manila: a cross-sectional study.docx by Danyelle Jay T. Cruz (20772668)

    Published 2025
    “…Among the injury factors studied, the location of pain at the hip/pelvis and knee was found to be significant (p < 0.05).</p>Discussion<p>Climbers in Metro Manila have a decreased tendency to engage in health-seeking behavior. …”
  13. 9113

    Data Sheet 1_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf by Zhen Guo (68566)

    Published 2025
    “…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …”
  14. 9114

    Data Sheet 6_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf by Zhen Guo (68566)

    Published 2025
    “…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …”
  15. 9115

    Data Sheet 3_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf by Zhen Guo (68566)

    Published 2025
    “…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …”
  16. 9116

    Data Sheet 2_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf by Zhen Guo (68566)

    Published 2025
    “…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …”
  17. 9117

    Data Sheet 4_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf by Zhen Guo (68566)

    Published 2025
    “…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …”
  18. 9118

    Data Sheet 5_Efficacy and safety of different medications compared for the treatment of postherpetic neuralgia: a network meta-analysis.pdf by Zhen Guo (68566)

    Published 2025
    “…The secondary outcomes showed a significant effect of hydromorphone in improving sleep quality (MD = −3.8, 95% CI: [−23.0, −15.0]) and decreasing pain questionnaire scores (MD = −13.0, 95% CI: [−28.0, 2.1]). …”
  19. 9119

    Table 1_Associations between physical activity and cardiorespiratory fitness and adverse outcomes in patients with atrial fibrillation: a prospective cohort study.pdf by Yanwen Chen (460790)

    Published 2025
    “…All levels of PA were significantly associated with a decreased risk of cardiovascular death with HRs ranging from 0.577 to 0.938 (P < 0.01). …”
  20. 9120

    Table 2_Associations between physical activity and cardiorespiratory fitness and adverse outcomes in patients with atrial fibrillation: a prospective cohort study.pdf by Yanwen Chen (460790)

    Published 2025
    “…All levels of PA were significantly associated with a decreased risk of cardiovascular death with HRs ranging from 0.577 to 0.938 (P < 0.01). …”